Autres langues AViTA Corporation

Actions

4735

TW0004735006

Equipement, fournitures et distribution médicale

Cours en clôture Taipei Exchange 24/09/2026			Varia. 5j.	Varia. 1 janv.
35,80 ^TWD	-0,14%		-0,42%	+11,53%

11/08	AViTA Corporation publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
14/05	AViTA Corporation publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Autres langues

11/08	AViTA Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
14/05	AViTA Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026
16/03	AViTA Corporation Reports Earnings Results for the Full Year Ended December 31, 2025
10/11	AViTA Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
31/07/25	AViTA Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
11/05/25	AViTA Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025
19/03/25	AViTA Corporation Reports Earnings Results for the Full Year Ended December 31, 2024
13/11/24	AViTA Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
13/08/24	AViTA Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
06/06/24	Avita Medical’s Cell Harvesting Device Treats First US Patient; Shares Rise 5%
31/05/24	Avita Medical's Recell Go Obtains Approval from US FDA
30/05/24	Avita Medical Shares Rise After FDA Nod For Recell Go System
30/05/24	Avita Medical Receives FDA Premarket Approval Supplement for Recell Go System
15/05/24	AViTA Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
14/05/24	Avita Medical Widens Q1 Loss as Sales, Marketing Expense Jumps; Shares Up 10%
11/04/24	Avita Medical Lowers Q1 Revenue Guidance on Slower New Account Approvals
20/03/24	AViTA Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
01/03/24	AVITA Medical Submits Additional RECELL GO PMA Supplement Information to US FDA
11/01/24	Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday on Expected Rate Cut Trajectory Insights
11/01/24	Avita Medical Signs US Distribution Agreement for Wound Healing Products
11/01/24	Avita Medical Signs Deal with Stedical Scientific for US Distribution of PermeaDerm
21/11/23	Avita Medical Lowers Fiscal 2023 Revenue Guidance
20/11/23	Avita Medical Lowers Guidance for 2023 Commercial Revenue
13/11/23	AViTA Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
10/11/23	Top Premarket Gainers